The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

Engaging in more than 150 minutes of physical activity per week quadrupled the odds of reversing prediabetes to normal ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.

(HealthDay News) — The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early type 2 diabetes ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

A total of 559 participants underwent randomization. The mean glycated hemoglobin level at baseline was 8.0%. At week 40, the estimated mean change from baseline in the glycated hemoglobin level ...

For adult women with overweight or obesity and T2D, replacing diet beverages with water is associated with greater weight loss and T2D remission.

Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...